Hyperuricemia: Is it a Risk Factor for Vascular Endothelial Dysfunction and Associated Cardiovascular Disorders?

E-ISSN： 1875-6506|5|1|1-6

ISSN： 1573-4021

Source： Current Hypertension Reviews, Vol.5, Iss.1, 2009-02, pp. : 1-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA

By Lentz S.R. Rodionov R.N. Dayal S.

Atherosclerosis, Supplements, Vol. 4, Iss. 4, 2003-12 ,pp. : 61-65

Elsevier

Access to resources Recommend Favorite

Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events

By Targonski P.V. Bonetti P.O. Pumper G.M. Higano S.T. Holmes D.R. Lerman A.

ACC Current Journal Review, Vol. 12, Iss. 5, 2003-09 ,pp. : 31-31

Elsevier

Access to resources Recommend Favorite

The vascular endothelial growth factor (VEGF) polymorphisms and the risk of endometriosis in northern Iran

By Emamifar Banafsheh Salehi Zivar Mehrafza Marzieh Mashayekhi Farhad

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 447-450

Informa Healthcare

Access to resources Recommend Favorite

Pleiotropic Beneficial Effects of Epigallocatechin Gallate, Quercetin and Delphinidin on Cardiovascular Diseases Associated with Endothelial Dysfunction

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 4, 2013-12 ,pp. : 249-264

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor Inhibitor Therapy and Cardiovascular and Renal Damage in Renal Cell Carcinoma

Current Vascular Pharmacology, Vol. 16, Iss. 2, 2018-01 ,pp. : 190-196

Bentham Science Publishers

Access to resources Recommend Favorite